Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Dr Gareth Williams
Room 323
UCL School of Pharmacy
29-39 Brunswick Square
  • Lecturer
  • Pharmaceutics
  • UCL School of Pharmacy
  • Faculty of Life Sciences

Gareth received a MChem (Hons) degree from the University of Oxford in 2002. He remained in Oxford working with Prof Dermot O’Hare for a DPhil (PhD) in materials chemistry, which was completed in 2005. Gareth then spent three years working in science programme management for the UK government, before returning to Oxford to take up a post-doctoral position in 2009. In September 2010 he joined London Metropolitan University as a Senior Lecturer in Pharmaceutical Science, and in November 2012 was appointed to the UCL School of Pharmacy as a Lecturer in Pharmaceutics. Gareth is a regular reviewer for a number of journals including Ind. Eng. Chem. Res., J. Solid State Chem., J. Mater. Chem., Angew. Chem., Int. J. Pharm., J. Pharm. Sci., Cryst. Growth Des., and J. Phys. Chem. He is a member of the Academy of Pharmaceutical Sciences New Scientists Focus Group, and has previously served as the Younger Members’ representative for the Royal Society of Chemistry Chiltern and Middlesex Section Trust Committee.

Research Summary

Inorganic drug delivery systems
A wide range of solid-state materials exists in which there is vacant space: it is often possible to fill this with a 'guest' species. We are using this chemistry to develop advanced materials with biomedical applications, for instance in drug or DNA delivery. Work is focussed on layered double hydroxides (LDHs) and hydroxy double salts (HDSs). These materials have positively charged layers, with charge-balancing anions located in the interlayer space (e.g. the LDH [LiAl2(OH)6]Cl.H2O or the HDS [Zn5(OH)8](NO3)2.H2O). A wide range of bioactive molecules can form anions and be incorporated into the interlayer region through replacement of the initial interlayer anion: these nanocomposites can be used to store and deliver drugs ina sustained manner. Such formulations can obviate the need to take frequent doses of medicines (making a patient's life easier) and help maintain drug levels at safe yet efficacious levels in the body. We are also interested in HDSs and LDHs for the separation of isomers of pharmaceutical agents. Often, we find they take up one isomer with a very high degree of preference. This offers a cheap and facile route to the separation of isomeric forms of a drug, ensuring efficacy and ameliorating toxic effects.

Polymeric drug delivery systems
A second strand of work comprises the exploration of nanoscale fibres, consisting of a polymer filament with functional components (e.g. drug molecules) embedded, as drug delivery systems. Fibres can be easily synthesised by electrospinning, in which a solution containing a polymer and a functional component is sprayed from a syringe towards a target collector with a high voltage applied between the two. The resulting materials have significant potential in increasing the solubility of poorly water soluble drugs, and may be exploited to drive "bottom-up" self-assembly processes. We are investigating the use of these materials for sustained drug delivery and for the precise targeting of drug molecules. 

Vaccine adjuvants
Vaccination saves 3 million lives annually through the induction of protective immunity to infection. For safety reasons, modern vaccines tend to contain pathogen subunits to which adjuvants, such as aluminium oxy-hydroxide (AlOOH; alum), must be added to deliver immunity. Alum provokes strong antibody-mediated immunity against bacterial toxins, but cannot stimulate the cellular immune response required to eliminate virally infected cells or cancers. Working with collaborators in Oxford and Ghent we are developing alternative inorganic vaccine adjuvants to drive different and/or more powerful immune responses, and have recently patented significant developments in this area.

Analytical techniques
Working with a range of collaborators at UCL and beyond, we are looking to combine synchrotron X-ray diffraction with thermal analysis techniques to obtain unprecedented levels of insight into phase transitions in pharmaceutical materials. The use of synchrotron radiation permits diffraction patterns to be collected in a few seconds, meaning that we can very rapidly observe changes in the nature of the solid materials present and correlate these with the heat signals simultaneously being monitored by calorimetry.

Teaching Summary

I teach pharmaceutics aspects of a number of modules in the UCL MPharm course, and also the MSc courses offered by the UCL School of Pharmacy. I am also course director for the MSc in Pharmaceutics and the MSc in Pharmaceutical Formulation & Entrepreneurship.

Please report any queries concerning the data shown on this page to https://www.ucl.ac.uk/hr/helpdesk/helpdesk_web_form.php
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by